MARSHALL WACE, LLP - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 174 filers reported holding ROCKET PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 2.61 and the average weighting 0.4%.

Quarter-by-quarter ownership
MARSHALL WACE, LLP ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$264,195
-83.8%
13,500
-86.7%
0.00%
-75.0%
Q3 2022$1,627,000
+756.3%
101,856
+638.1%
0.00%
Q2 2022$190,000
-90.9%
13,800
-85.6%
0.00%
-100.0%
Q4 2021$2,085,000
+7.4%
95,569
+170.0%
0.00%
-63.6%
Q4 2020$1,941,000
+2105.7%
35,390
+812.8%
0.01%
+1000.0%
Q4 2019$88,000
+486.7%
3,877
+197.3%
0.00%
Q3 2019$15,000
-99.2%
1,304
-99.0%
0.00%
-100.0%
Q2 2019$1,977,000
-61.4%
131,748
-54.9%
0.02%
-33.3%
Q1 2019$5,120,000291,9840.02%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
M28 Capital Management LP 523,280$10,722,00712.30%
RTW INVESTMENTS, LP 17,687,772$362,422,4487.65%
Logos Global Management LP 1,975,000$40,467,7505.40%
ACUTA CAPITAL PARTNERS, LLC 362,000$7,417,3804.97%
New Leaf Venture Partners, L.L.C. 118,242$2,422,7793.11%
MAVERICK CAPITAL LTD 5,629,970$115,358,0852.60%
Ghost Tree Capital, LLC 295,000$6,044,5501.99%
Frazier Life Sciences Management, L.P. 1,403,013$28,747,7361.91%
Ikarian Capital, LLC 654,726$13,415,3351.61%
Boxer Capital, LLC 1,466,051$30,039,3851.60%
View complete list of ROCKET PHARMACEUTICALS INC shareholders